INO Trade on May 22, 2020 10:07 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Human trials for COVID-19 vaccine to start in April
-February 7, 2020: $100m offering
-March 9 2020: $50m ATM offering
-March 11 2020: WHO declares COVID-19 a pandemic
-March 13 2020: US declares COVID-19 national emergency
-March 26 2020: Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
-April 06 2020: Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
-April 28 2020: Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine
-May 20 2020: COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

Technical Analysis

-SPY pattern: Runner
-Intraday pattern: Consolidation
-Levels: 13.2, 14, 14.5

Strategy / Confluence / Sizing Guide / Risk

Strategy: FT-15 short of 13.3 level
Confluence: Prior Close
Strike Zone: 14.3 - 14.45
Sizing (lots): 3
Risk (stop / Rs): Hold above 14.5

Review / Lessons Learned

Happy on how I managed the loss, it was holding above 14.50, so I started slowly stopping out in the 14.40's, got flat when PA went back to my average. The main mistake here was this wasn't a first test because the level already got tested yesterday...

Lessons Learned: DON'T TAKE THE 2nd TEST!!! First time at well is best!